EarningsNovo Nordisk Surges 24.9% in 30 Days After Q1 Beat, Bets on AI Partners Over In-House R&DSalvado•Jun 9, 2026
Pharma SectorNovo Nordisk Shares Surge 24.9% After Parkinson's AI Deal and Cell Therapy ExitSalvado•May 13, 2026
Sector AnalysisNVIDIA's Biotech AI Push Positions Semiconductor Giant at Center of $100B Drug Discovery MarketSalvado•Apr 11, 2026
Tech Sector GrowthNVIDIA BioNeMo Platform Secures Lilly and Thermo Fisher as AI Drug Discovery PartnersSalvado•Mar 26, 2026
Biotech SectorNVIDIA's BioNeMo Bets Big on Drug Discovery as Specialized AI Rivals EmergeViaNews Editorial Team (Markets)•Feb 18, 2026
